Aurobindo Pharma Limited — Others, 07-05-2025: Disclosure under SEBI Takeover Regulations

Aurobindo Pharma’s promoters and promoter group confirmed no new encumbrances on their 30.09 crore shares, representing 51.82% of equity, beyond previously disclosed ones. This indicates stable promoter holding with no fresh pledges or liens, reinforcing confidence in promoter commitment and reducing concerns over potential forced share sales or liquidity pressures from the promoter side.